1.13

0.00% 0.00

Inovio Pharmaceuticals Inc (INO)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Inovio Pharmaceuticals Inc stock is traded at $1.13, with a volume of 2.75M. It is up +0.00% in the last 24 hours and down -35.06% over the past month. Inovio Pharmaceuticals Inc is a clinical-stage biotechnology company focused on developing and commercializing DNA medicines to help treat and protect people from diseases associated with human papillomavirus (HPV), cancer and infectious diseases. INOVIO's platform harnesses the power of in vivo protein production, featuring optimized design and delivery of DNA medicines that teach the body to manufacture its own disease-fighting tools. Its candidate is INO-3107 for the treatment of recurrent respiratory papillomatosis (RRP), a chronic, rare and debilitating disease of the respiratory tract caused by HPV infection. In its completed Phase 1/2 clinical trial of INO-3107 for the treatment of HPV-6 and HPV-11-associated RRP.

Previous Close:

$1.13

Open:

$1.15

24h Volume:

2.75M

Relative Volume:

1.94

Market Cap:

$77.73M

Revenue:

$65,300

Net Income/Loss:

$-84.95M

P/E Ratio:

-0.5845

EPS:

-1.9332

Net Cash Flow:

$-88.92M

1W Performance:

-32.34%

1M Performance:

-35.06%

6M Performance:

-53.11%

1Y Performance:

-27.56%

1-Day Range:

$1.11

$1.15

1-Week Range:

$1.065

$1.785

52-Week Range:

$1.065

$2.9789

Inovio Pharmaceuticals Inc Stock (INO) Company Profile

Name

Inovio Pharmaceuticals Inc

Sector

Healthcare (1117)

Industry

Biotechnology (624)

Phone

(858) 410-3134

Address

660 W. GERMANTOWN PIKE, PLYMOUTH MEETING, PA

Employee

112

Twitter

@inoviopharma

Next Earnings Date

2026-03-12

Latest SEC Filings

INO's Discussions on Twitter

Compare INO vs VRTX, REGN, ARGX, ALNY, INSM

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
INO Inovio Pharmaceuticals Inc	1.125	78.07M	65,300	-84.95M	-88.92M	-1.9332
VRTX Vertex Pharmaceuticals Inc	433.58	111.45B	12.07B	3.95B	3.19B	15.33
REGN Regeneron Pharmaceuticals Inc	762.51	80.54B	14.34B	4.50B	3.77B	41.56
ARGX Argen X Se Adr	747.05	46.32B	4.16B	1.29B	734.26M	19.58
ALNY Alnylam Pharmaceuticals Inc	330.89	42.29B	3.71B	313.75M	465.38M	2.2571
INSM Insmed Inc	163.74	35.01B	606.42M	-1.28B	-997.58M	-6.403

Inovio Pharmaceuticals Inc Stock (INO) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Jul-09-25	Initiated	Piper Sandler	Overweight
May-14-24	Initiated	Stephens	Overweight
Jan-25-24	Upgrade	Oppenheimer	Perform → Outperform
Nov-09-22	Downgrade	Maxim Group	Buy → Hold
Nov-01-22	Downgrade	BofA Securities	Neutral → Underperform
Jul-19-22	Resumed	RBC Capital Mkts	Sector Perform
May-11-22	Downgrade	Oppenheimer	Outperform → Perform
Jan-21-22	Upgrade	BofA Securities	Underperform → Neutral
Dec-29-21	Resumed	Jefferies	Hold
Sep-10-21	Downgrade	BofA Securities	Neutral → Underperform
Jun-24-21	Initiated	Jefferies	Hold
Mar-23-21	Initiated	BofA Securities	Neutral
Feb-12-21	Initiated	Oppenheimer	Outperform
Nov-17-20	Downgrade	ROTH Capital	Neutral → Sell
Nov-10-20	Upgrade	ROTH Capital	Sell → Neutral
Sep-28-20	Downgrade	Cantor Fitzgerald	Overweight → Neutral
Sep-28-20	Upgrade	Maxim Group	Hold → Buy
Jul-01-20	Downgrade	Maxim Group	Buy → Hold
Jul-01-20	Downgrade	ROTH Capital	Neutral → Sell
Jun-29-20	Downgrade	H.C. Wainwright	Buy → Neutral
Jun-26-20	Downgrade	Stifel	Buy → Hold
May-21-20	Initiated	The Benchmark Company	Buy
Apr-30-20	Downgrade	ROTH Capital	Buy → Neutral
Mar-13-20	Downgrade	Piper Sandler	Overweight → Neutral
Mar-13-20	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Dec-19-19	Initiated	ROTH Capital	Buy
Feb-15-18	Reiterated	Maxim Group	Buy
Oct-18-17	Initiated	RBC Capital Mkts	Outperform
Sep-06-17	Initiated	Citigroup	Buy
Jun-08-17	Upgrade	Piper Jaffray	Neutral → Overweight
May-24-17	Reiterated	Maxim Group	Buy
Mar-16-17	Upgrade	Maxim Group	Hold → Buy
Mar-16-17	Downgrade	Piper Jaffray	Overweight → Neutral

View All

Inovio Pharmaceuticals Inc Stock (INO) Latest News

12:00 PM

Bronstein, Gewirtz & Grossman LLC Urges Inovio - globenewswire.com

12:00 PM

10:50 AM

Portnoy Law Firm Announces Class Action on Behalf of Inovio Pharmaceuticals, Inc. Investors - WFXG

10:50 AM

10:42 AM

DEADLINE ALERT for TCPC, ORCL, PSFE, and INO: The Law - globenewswire.com

10:42 AM

10:31 AM

Inovio: 'Hold' As Upcoming PDUFA For INO-3107 Is Major Inflection Point (NASDAQ:INO) - Seeking Alpha

10:31 AM

09:30 AM

Inovio prices $17.5 million public offering of shares and warrants - MSN

09:30 AM

09:22 AM

Inovio Pharmaceuticals Announces New Public Equity Offering - tipranks.com

09:22 AM

07:13 AM

Inovio Pharmaceuticals Launches $16 Million Stock-and-Warrant Offering Underwritten by Piper Sandler - TradingView

07:13 AM

07:03 AM

Inovio (Nasdaq: INO) prices $17.5M stock and dual-warrant public offering - Stock Titan

07:03 AM

02:44 AM

INO Investors Have Opportunity to Lead Inovio Pharmaceuticals, Inc. Securities Fraud Lawsuit with the Schall Law Firm - prnewswire.com

02:44 AM

Apr 05, 2026

INO FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Inovio Pharmaceuticals Inc. ... - Caledonian Record

Apr 05, 2026

UNIQURE DEADLINE: ROSEN, A LEADING AND LONGSTANDING FIRM, Encourages uniQure N.V. Investors with Losses in Excess of $100K to Secure Counsel Before Important April 13 Deadline in Securities Class Action - GlobeNewswire Inc.

Apr 05, 2026

INO FINAL DEADLINE: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, - globenewswire.com

Apr 05, 2026

Inovio Pharmaceuticals Faces Stock Dilution and Legal Battles - timothysykes.com

Apr 05, 2026

Stock Report: Is Inovio Pharmaceuticals Inc a potential multi baggerQuarterly Earnings Summary & Consistent Profit Trading Strategies - baoquankhu1.vn

Apr 05, 2026

Apr 04, 2026